What are the funding trends in AgriTech right now?

All funding deals in the AgriTech market over the last years

Below is the table listing all the deals. You can find our methodology at the end of this page.

If you want a deeper understanding of the market and its current dynamics, get our report covering the AgriTech Market.

Is AgriTech funding actually falling right now?

AgriTech funding is clearly weaker today, and the drop is much deeper than the headline dollar figure makes it look.

We counted 86 financings from January 1 to September 21, 2026, against 100 over the same period in 2025 and 114 in 2024. The number of funded companies fell even faster year over year, from 100 to 84.

Capital looks better at first. The companies we tracked raised $919.5 million, only 9.6% below the $1.017 billion recorded over the comparable 2025 period.

Take out rounds above $50 million, though, and funding drops from $773.5 million to $535.5 million. That is a 30.8% fall. The same adjusted measure is down 34.4% from 2024.

Today's AgriTech market is therefore considerably thinner than the top-line funding number suggests. Fewer companies are raising, fewer deals are happening, and the part of the market below the giant rounds has lost roughly a third of its capital in one year.

Metric	2026 YTD	2025 YTD	2024 YTD
Deals	86	100	114
Unique funded companies	84	100	112
Total calculable capital	$919.5M	$1.017B	$1.285B
Capital excluding >$50M rounds	$535.5M	$773.5M	$816.8M
Capital excluding >$100M rounds	$594.5M	$873.5M	$898.8M
Median round	$5.4M	$4.13M	$4.0M
Largest round	$220M	$144M	$150M

Are fewer AgriTech startups getting funded, or are rounds just getting smaller?

Fewer AgriTech startups are getting funded, while the companies that do raise are actually closing larger typical rounds.

Deal count is down 14% from last year and the number of funded companies is down 16%, yet the median round has climbed from $4.13 million to $5.4 million.

The mix of deals explains a lot. Financings below $5 million made up 58.2% of known-size rounds last year. Today they represent 47.5%. At the same time, the $5 million to $20 million bracket has jumped from 29.6% to 42.5%.

We can see that middle range in actual transactions. AgriPass raised $7.5 million to scale its robotic weed-control platform. Upside Robotics raised another $7.5 million as it expands autonomous fertilizer application. AgZen closed a $10 million Series B after saying deployment of its RealCoverage system had grown 15-fold in one season and had reached nearly one million commercial acres.

Investors are still writing meaningful checks. The harder part these days is getting into the group that receives one.

Is Halter's $220 million round making AgriTech look healthier than it really is?

Yes. Halter's $220 million Series E changes the appearance of the entire AgriTech market.

That single financing represents 23.9% of all calculable capital we tracked this year. The three largest rounds together account for 41.8%, and the five largest reach 48.2%.

Last year, the largest deal contributed 14.2% of capital and the top five 38.7%. Concentration has moved sharply higher. As deals concentrate, where investors still put money, and what they now avoid, becomes the story we follow in our AgriTech market report.

Halter also deserves to be treated differently from the average startup. When it announced the financing, the company said more than 2,000 farmers and ranchers were already using the platform and that one million solar-powered collars had been sold. The new money is going into commercial expansion across the US, Australia, New Zealand and new international markets.

Tropic gives us a second example at a smaller scale. Its $105 million Series C came after the company commercially launched new banana varieties and said demand was already exceeding supply.

Large investors are clearly willing to fund AgriTech businesses that have crossed into real commercial scale. That currently coexists with a much smaller pool of companies getting financed overall.

Concentration measure	2026 YTD	2025 YTD	2024 YTD
Largest round	$220M	$144M	$150M
Top 1 share of capital	23.9%	14.2%	11.7%
Top 3 share	41.8%	28.9%	30.0%
Top 5 share	48.2%	38.7%	39.5%
>$50M rounds	3	2	4
>$100M rounds	2	2	3
Capital excluding >$50M	$535.5M	$773.5M	$816.8M

Is Series A becoming the hardest AgriTech round to raise?

Yes. Series A is currently the clearest weak spot in AgriTech funding.

We found only 11 Series A rounds this year. There were 21 over the same period in 2025 and 32 in 2024. In two years, the count has fallen by almost two-thirds.

Seed has gone the other way. We counted 43 Seed rounds today, versus 41 last year and 35 in 2024. Half of all current AgriTech financings are now Seed deals.

That leaves a fairly obvious gap in the middle of the startup journey. New teams are still finding early money, and mature companies can still raise huge follow-ons, but far fewer businesses are showing up at Series A.

UBEES is one of the companies that did get through. Its €8 million Series A is being used to expand pollination services and agricultural data operations. Agriodor also raised €15 million at Series A as it moves its olfactory crop-protection technology into more markets.

Series A capital is available. There are just far fewer rounds than there used to be.

Stage	2026 deals	2025 deals	2024 deals	2026 median
Seed	43	41	35	$3.0M
Series A	11	21	32	$9.45M
Series B	9	14	10	$11.5M
Series C	4	2	7	$29.8M
Series D+	1	4	1	$220M
Growth Equity	3	1	8	$9.45M
Unknown	15	17	21	$4.6M

Are AgriTech investors mostly backing companies they already know?

Increasingly, yes. Follow-on companies are absorbing a much larger share of AgriTech capital than startups raising for the first time.

We identified 21 first financings this year, compared with 26 last year. That is a noticeable decline, although first financings still represent almost one quarter of all deals.

The bigger difference is money. First-financing capital fell from $119.7 million to $57.3 million. Follow-on capital stayed much more resilient at roughly $864 million, down only modestly from $897.3 million.

Typical check sizes also diverge. The median first financing is $2.12 million, while the median follow-on has reached $7.3 million.

Several current deals fit that pattern. AgZen came back one year after its $10 million Series A and raised another $10 million at Series B. AquaExchange returned with an $8 million Series B after previously raising a Series A. Tropic and Halter sit much further up the same curve.

Our first-financing classification is deliberately directional because private-company funding histories are not always perfectly reconstructable. Even with that caveat, the dollar gap is too large to ignore. Capital is flowing much more comfortably toward businesses that have already convinced investors once before.

Which AgriTech category is getting hotter right now?

Precision Agriculture Tools have the clearest broad rebound in our AgriTech data today.

We found 12 financings in the category this year, up from only five over the comparable 2025 period. Its share of AgriTech deals has climbed from 5% to 14%.

Several different companies are contributing. AgZen raised $10 million after rapid commercial adoption of its spray-optimization technology. VitalFluid announced a €17.2 million funding package to expand its crop-protection system after moving from pilots into multi-year commercial contracts with British strawberry growers. The equity component we count is approximately $16.8 million because the package also contains a €2.7 million public Innovation Credit. Pilots turning into multi-year contracts show technology that works, and we sort that from what is still on paper in our report on AgriTech.

AgriPass is also trying to commercialize robotic weed control across the US and Europe after raising $7.5 million. More recently, Tellia raised a $5 million pre-seed for its voice-based farm interface and said its platform was already live across one million acres.

This rebound is broader than one outsized deal. Still, 2024 had 16 Precision Agriculture financings over the same months, so the category has really bounced back from a weak 2025 rather than suddenly appearing from nowhere.

Is Farm Automation actually booming?

Farm Automation is attracting a lot of money today, but the number of funded automation companies has gone down.

We counted 19 Farm Automation deals, versus 25 last year. Yet the category captures 36.8% of all current AgriTech capital.

Halter is a huge reason for that gap, although several smaller automation financings show that investors are still active below the top end. AgriPass raised $7.5 million for autonomous weed control. Upside Robotics raised the same amount for fertilizer robots. AquaExchange secured $8 million for its aquaculture technology platform.

Agovor offers a useful example at the earlier end. The horticultural robotics company closed an AU$3 million pre-seed led by Tenacious Ventures, with backing from Hort Innovation's investment fund. The company was built around a straightforward farm problem: labor is expensive and increasingly difficult to find.

Farm Automation has deep pockets behind some winners and a healthy range of applications. What it does not have is growing deal volume.

Are Agricultural Biologicals starting to cool off?

Agricultural Biologicals are still the busiest part of AgriTech, but investors are putting a smaller share of total money into the category.

We tracked 23 Biologicals financings this year, down from 29 in 2025 and 30 in 2024. That leaves the category at 26.7% of all deals, still the largest share in our market.

Its capital share has dropped more sharply, from 38.5% last year to 27.8% today.

Tropic's $105 million Series C makes that decline particularly striking because one of the biggest deals of the entire year sits inside this category. Beneath Tropic, Amatera raised €6 million to accelerate climate-resilient crop breeding, while Agriodor raised €15 million to expand scent-based biocontrol.

Those companies also show why Biologicals remain interesting. Tropic is scaling commercial gene-edited crops, Amatera says its platform can speed up crop development using cell biology, robotics and AI, and Agriodor has already commercialized its first product through an agreement with Syngenta.

There is still plenty happening in Biologicals. What has cooled is the amount of capital the category captures relative to the rest of AgriTech.

Category	2026 deals	2025 deals	2026 capital share	2026 median
Agricultural Biologicals	23	29	27.8%	$5.0M
Farm Automation Systems	19	25	36.8%	$7.5M
Animal Health Technologies	15	17	12.1%	$3.0M
Precision Agriculture Tools	12	5	9.6%	$7.3M
Farm Sensing Platforms	12	18	8.3%	$4.8M
Farm Management Software	5	6	5.3%	$5.0M
Total AgriTech market	86	100	100%	$5.4M

Is Farm Sensing losing investor attention?

Farm Sensing is one of the clearer weak areas in AgriTech right now because both its deal share and its capital share have fallen.

The category dropped from 18 financings last year to 12 today. Its share of deals fell by four percentage points, while its share of capital slipped by almost five points.

There are still good-sized rounds. 701x closed a $10 million Series B and said it had reached profitability while preparing a global expansion. TerraBlaster raised $12.5 million for real-time soil nutrient mapping. vGreens added roughly $2.3 million.

But six fewer deals in a market that is already shrinking is meaningful. Farm Sensing has weakened faster than AgriTech overall, and unlike Farm Automation, there is no giant transaction lifting its dollar share back up. What sensing companies need to see before demand picks up is among the growth drivers we weigh in our market report about AgriTech.

Has Europe really overtaken North America in AgriTech funding?

For now, yes. Europe has become the biggest region in our AgriTech dataset by both deal count and capital, and the shift is surprisingly large.

We counted 44 European financings this year, up from 31 over the same period last year. Europe now represents 51.2% of all deals and 48.4% of capital.

North America fell from 42 deals to 19. Its capital share dropped from 62.8% to 17.2%.

Tropic adds a lot to Europe's dollar total, but 44 separate deals cannot be explained by Tropic alone. Agriodor, UBEES, Amatera and VitalFluid are all meaningful European raises in different parts of the market.

North America's decline is similarly broad. There are simply far fewer financings showing up this year.

One nine-month period is not enough to declare a permanent change in the global center of AgriTech. Still, the current gap is far too large to dismiss as normal statistical noise.

Is Asia-Pacific AgriTech growing as fast as Europe?

No. Asia-Pacific is seeing bigger AgriTech checks, while Europe is seeing both more deals and more money.

APAC represents 20.9% of deals today, almost unchanged from last year. We counted 18 financings, compared with 21 during the same period in 2025.

Its capital share has jumped from 17% to 30.4%, and Halter explains a large portion of that increase.

There is activity beyond Halter. AquaExchange raised $8 million at Series B, Verdant Impact secured $3 million and Agovor closed its AU$3 million pre-seed. Those examples show a functioning startup market across the region.

Still, the number of financed companies has not expanded. Europe currently has a much broader upswing.

Why are corporate investors showing up more often in AgriTech?

Corporate investors are much more visible in AgriTech this year, especially where startups plug directly into seeds, crop protection, equipment or agricultural distribution.

Strategic investors participated in 27.9% of the deals we tracked, up from 19% last year. The median strategic-backed round also increased from $6.2 million to $8.1 million.

Corteva co-led Tropic's $105 million financing as Tropic scales its crop portfolio. Syngenta Group Ventures invested in AgZen alongside a commercial partnership. Seed company Bejo invested in Antonie after working with the startup on AI tools for crop monitoring. VDL participated in VitalFluid's financing as that company moves further into commercial crop protection. Startups that team up with established players are a pattern worth watching, and we study what leaders consistently do differently in our report on AgriTech.

The logic is fairly practical. Many of these startups need access to farms, agronomists, seed production, distribution channels or regulatory expertise. An industrial investor can bring more than money.

There is one useful reality check. Strategic participation was 28.9% in 2024, almost exactly where it stands today. The current increase looks like a strong recovery from a quiet 2025 rather than a brand-new record.

Are AgriTech investors becoming more selective?

Yes. AgriTech investors currently look more selective about which companies receive capital, while remaining willing to fund the companies that clear that bar.

Several parts of the market point in the same direction. We have fewer funded companies, the Series A layer has become much thinner, first-financing dollars have fallen sharply, and the number of unique disclosed lead investors dropped from 87 last year to 76.

At the same time, the median round is higher. The $5 million to $20 million bracket is much more prominent. Follow-on companies are still raising substantial sums.

Recent company announcements also show what investors appear to reward. Halter came to market with thousands of farms already using its system. AgZen reported a 15-fold increase in deployed acreage. VitalFluid had moved from trials into multi-year commercial contracts. Tropic said demand for its new banana varieties was already greater than supply.

That does not tell us why every rejected AgriTech company failed to raise. It does show what several of the companies getting funded today have in common: commercial use, measurable adoption or a credible path to scale.

Are AgriTech startups getting older before they can raise money?

No. AgriTech companies are not getting materially older before financing, even though investors appear more selective.

The median company in our 2026 deals is five years old at the time of financing. It was also five years old last year and six in 2024.

Age increases fairly naturally by stage. The current median is four years at Seed, seven at Series A, eight at Series B and nine at Series C.

Agricultural Biologicals are actually getting younger. The median company age in that category fell from seven years last year to 3.5 years now.

Company age therefore looks like a weak explanation for the larger median financing we see today. Investors are choosing fewer companies, but there is no broad evidence that they are simply waiting several extra years before writing a check.

Could AgriTech funding still finish 2026 strongly?

It could, but today's data does not give us a good reason to call 2026 a strong AgriTech funding year yet.

By September 21, the market had reached about 64% of 2025's full-year calculable capital and roughly 63% of its deal count. Against full-year 2024, the current figures are around 53% of capital and 58% of deals.

More than three months remain, so those comparisons are context rather than forecasts. Venture funding is too lumpy to multiply nine months of activity by a simple annualization factor. Funding this lumpy needs fresh data, which is why our AgriTech market report is updated every quarter.

A single $150 million round could transform the year-end capital chart while barely changing the experience of most founders. A burst of 20 Seed and Series A deals could do the opposite: deal breadth would improve considerably without producing a spectacular funding headline.

For now, AgriTech has entered the final part of the year with fewer funded companies and much weaker capital below the megaround layer than at the same point in either of the previous two years.

What is actually changing in AgriTech funding?

AgriTech funding has become narrower and more selective this year, even though strong companies can still raise large checks.

The biggest change is breadth. We are seeing fewer deals, fewer funded companies and fewer active lead investors. Once the biggest rounds are removed, the decline in capital is much steeper than the headline total suggests.

The next change is where companies are getting stuck. Seed remains active, but Series A has fallen from 32 comparable deals two years ago to 11 today. That is currently the clearest break in the financing pipeline.

Capital is also moving toward companies with previous funding and visible commercial traction. Halter, Tropic, AgZen and VitalFluid illustrate different versions of that pattern, from large-scale adoption to commercial product launches and customer contracts.

Investor attention is rotating inside AgriTech as well. Precision Agriculture has bounced back strongly. Farm Automation is taking a disproportionate share of dollars despite fewer deals. Agricultural Biologicals remain busy but have lost funding intensity, while Farm Sensing has weakened on both fronts.

Geography has shifted unusually fast. Europe has gained deal breadth as well as capital, North America has contracted sharply, and APAC's stronger dollar total is much more concentrated around large deals.

Corporate investors are more visible again, especially around technologies that benefit from existing seed, crop-protection, equipment and distribution networks. The current strategic-investor share, however, is close to its 2024 level, so this looks more like a rebound than a completely new regime.

The picture as of now is fairly clear: AgriTech still has money, but that money is reaching a smaller set of companies. The strongest current funding pattern is commercial proof. The geographic shift deserves more caution, because one strong European year does not establish a permanent reordering of the global AgriTech market.